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ABSTRACT
Objective: the alteration of hormones regulating sodium and
water status is related to renal failure in obstructive jaundice (OJ).
Experimental design: OJ was induced by common bile duct
ligation. Samples were obtained from the control (SO) and OJ
groups at 24 and 72 hours, and at 7 days. Different parameters
related to biliary obstruction, liver and renal injury, and vasoactive
mediators such as renin, aldosterone, endothelin-1 (ET-1) and
prostaglandin E2 (PGE2) were studied.
Results: bile duct ligation caused an increase in total bilirubin
(p < 0.001) and alkaline phosphatase (AP) (p < 0.001). The SO
and OJ groups had the same values for diuresis, renin, and creati-
nine clearance at 24 h. However, animals with OJ had a lower
sodium concentration in urine than SO animals (p < 0.01), as well
as an increase in aldosterone levels (p < 0.03). ANP levels were
moderately increased during OJ but did not reach statistical signif-
icance when compared to the SO group. In contrast, OJ animals
showed a rise in serum ET-1 concentration (p < 0.001) and in-
creased PGE2 in urine (p < 0.001).
Conclusions: biliary obstruction induced an increase in ET-1
release and PGE2 urine excretion. These hormones might play a
role during the renal complications associated with renal distur-
bances that occur during OJ.
Key words: Aldosterone. Creatinine. Endothelin-1. Obstructive
jaundice. Renal dysfunction. Renin.
ABBREVIATIONS
AP: alkaline phosphatase.
ET-1: endothelin-1.
OJ: obstructive jaundice.
PGE2: prostaglandin E2.
SO: Sham operated.
INTRODUCTION
Cholestasis is a clinical and biochemical syndrome
caused by the impaired bile flow often associated with
extrahepatic complications (1). Acute renal failure is a
major complication of obstructive jaundice (OJ), with 8%
incidence in several series (2). Biliary obstruction was
first linked to renal failure in the early study carried out
by Clairmont and von Haberer (1910) (3). Several hy-
potheses have sought to explain the pathogenesis of renal
dysfunction in OJ. The depletion of the extracellular
compartment (4), myocardial dysfunction, and altered
hemodynamic status (5) have been linked to renal failure
in biliary obstruction. In addition, severe oxidative stress
has been implicated in the renal dysfunction associated to
experimental OJ (6,7) as well as other liver diseases (8).
Other lines of research have looked at the involvement of
vasoactive mediators such as endothelin-1 (ET-1). ET-1
is a powerful paracrine vasoconstrictor that acts by
means of specific type-A and type-B receptors. In bio-
chemical terms, it is a 21-amino acid peptide derived
from what is known as big ET-1 by the action of the en-
dothelin-converter enzyme. It is synthesized mainly by
endothelial cells and to a lesser degree by stellate cells in
the liver and biliary epithelium (9,10). ET-1 changes have
been related to different human diseases (11). ET-1 both
acts on the mesangial cells and causes vasoconstriction in
the renal microcirculation, which may contribute – along-
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side factors such as endotoxemia, extracellular volume
depletion, and myocardial dysfunction, to a drop in
glomerular filtration and the development of renal failure
in OJ. However, vasoactive compensatory hormones
such as prostaglandin E2 (PGE2) and atrial natriuretic
peptide (ANP) may play a role in the preservation of re-
nal function during OJ (5,6). The aim of this study was to
determine the status of hormones regulating sodium and
water, as well as different vasoactive mediators affecting
renal function during experimental OJ.
METHODS
Animals
Male Wistar rats (300-375 g) were subjected to con-
trolled conditions of temperature (about 22 ºC) and illu-
mination (12 h light:12 h dark cycle), and were provided
with food (Ebro Agrícolas®, Seville, Spain) and water ad
libitum. Food metabolized energy at 2375 cal/kg. Rats
were put in metabolic cages for several days before
surgery, and for seven days after surgery. The animals
were treated according to institutional guidelines and the
study was approved by the Research Committee of Reina
Sofia University Hospital.
Experimental design
Animals were divided into three groups: baseline (n =
5), sham operated (SO, n = 15), and OJ (n = 15) for 7
days. The SO and OJ groups were divided into three sub-
groups for extracting samples at 24 and 72 hours, as well
as at 7 days after surgery. Animals were anesthetized
with pentobarbital (Nembutal® 50 mg/kg/i.p.) for all sur-
gical procedures. Cephazoline (17 mg/kg/i.m.) was used
as antibiotic prophylaxis. SO animals were submitted to
laparotomy and abdominal closure without bile duct in-
tervention. The procedure for OJ was initiated by a mid-
line ventral incision with exposure of the extra-hepatic
bile duct. A double ligature with silk suture was tied and
the bile duct was sectioned. A two-layer running suture
was used for abdominal closure with Dexon (Braun Dex-
on, Barcelona, Spain) and Mersilk (Ethicon, Brussels,
Belgium) material. The animals were killed under anes-
thesia 24 hours, 72 hours or 7 days later. Blood was col-
lected from the abdominal aorta and the serum was
frozen at -20 ºC until biochemical parameters were mea-
sured. For hormone assays and ET-1, blood samples were
collected in chilled tubes containing EDTA (2 mg/ml)
and aprotinin. Samples were centrifuged at 3000 rpm for
10 min at 4 ºC, within 30 min of collection. The plasma
was decanted and stored frozen at -70 ºC for subsequent
analysis. Urine was collected in plastic tubes, centrifuged
at 3500 rpm for 20 min at 4 ºC, aliquoted, and frozen at -
20 ºC for later study.
Determination of biochemical parameters
Total bilirubin, alkaline phosphatase (AP), sodium,
and creatinine were measured in the serum using an
Axon autoanalyzer (Bayer Diagnostics, Tarrytown, NY,
USA). Sodium and creatinine were also measured in the
urine using an Axon autoanalyzer (Bayer Diagnostics,
Tarrytown, NY, USA). Creatinine clearance was calculat-
ed using serum creatinine and 24-hour urinary creatinine
excretion.
Measurement of ET-1, PGE2, and hormones
Plasma ET-1 levels were determined by enzyme im-
munoassay (kit BBE5) according to the manufacturer’s in-
structions (RD Systems Europe, Abingdon, UK). PGE2 in
urine was determined by enzyme immunoassay (kit
DE0100) according to the manufacturer’s instructions (RD
Systems Europe, Abingdon, UK). The amount of PGE2 ex-
creted in urine was calculated from the formula: concentra-
tion of PGE2 in urine x volume per minute of urine.
ANP, renin, and aldosterone
Radioimmunoassay techniques with intra-assay varia-
tion coefficients of 5 and 6% were used to determine
ANP (h-ANP, Cob. I-AR55TM Tokyo, Japan; reference
values 20-60 pg/ml), renin (a-Renin IRMA 4K-REN-
00TM; Future Diagnostics, Wijchen, The Netherlands),
and aldosterone (ACTIVETM aldosterone; Diagnostic
Systems Laboratories, Webster, Texas, USA) levels.
Statistical analysis
A multivariate ANOVA model, known as the General
Linear Model for repeated measurements, was used. A
significance level of p < 0.1 was allowed for this model.
To compare quantitative variables, Student’s t test was
used for non-paired data. The SPSS 7.5 programme for
Windows conducted the statistical analysis.
RESULTS
The mean values of the parameters studied are found
in table I. Animals with bile duct obstruction showed an
increase in cholestasis, total bilirubin, and AP when com-
pared to SO animals. The evaluation of renal function pa-
rameters (24-hour diuresis and creatinine clearance) in
animals with OJ showed a trend towards more diuresis
versus SO animals, though differences were not signifi-
cant. In addition, animals with OJ had a lower sodium
concentration in urine as compared to its increase
throughout the study in SO animals. Hormones in the
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renin-angiotensin-aldosterone axis were determined.
There were no significant differences between the SO
and OJ groups for serum renin concentrations. However,
serum aldosterone in OJ rats was two-fold that of SO rats.
There was a rise in ANP in animals with OJ, although
there were no significant differences with the SO group.
ET-1 and PGE2 in urine were significantly enhanced in
OJ animals as compared to SO animals. SO animals also
showed a significant increase in PGE2 throughout the
study. When ET-1 and PGE2 were compared with creati-
nine clearance in animals with OJ, rats with poorer renal
function had higher ET-1 values and lower PGE2 concen-
trations in urine (Figs. 1 and 2).
DISCUSSION
One of the main consequences of biliary obstruction is
its effect on renal function, which markedly increases pa-
tient morbidity and mortality. The experimental study re-
ported here tried to determine whether certain factors that
affect renal perfusion contributed to the renal failure oc-
curring in OJ. Although the rise in total bilirubin and AP
showed that bile duct ligation induced cholestasis, the
data related to renal function such as 24-hour diuresis
and/or creatinine clearance showed no significant differ-
ences between the OJ and SO groups, though diuresis
was higher in OJ rats. This could be attributed to the short
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Table I. Comparison of variables in rats with obstructive jaundice (OJ) vs. sham operation (SO)
Baseline 24 h 72 h 7 days p intragroup Intergroup
Total bilirubin (mg/dl)
SO 0.1 ± 0.01 0.1 ± 0.01 0.1 ± 0.01 0.1 ± 0.01 n.s. < 0.001
OJ 0.1 ± 0.01 3.05 ± 0.300 7.2 ± 1.90 7.2 ± 2.70 < 0.001
Alkaline phosphatase (U/l)
SO 240 ± 90 271 ± 46 209 ± 43 205 ± 45 n.s < 0.001
OJ 236 ± 95 1925 ± 303 870 ± 148 660 ± 299 < 0.001
Urine output
(ml/24 h)
SO 10 ± 2.9 8.8 ± 4.50 10 ± 2.7 9.8 ± 1.00 n.s. n.s.
OJ 13 ± 4.2 13 ± 6.6 11 ± 3.2 12 ± 5.1 n.s.
Creatinine clearance (ml/min)
SO 1.68 ± 1.070 1.33 ± 0.760 1.31 ± 0.280 1.11 ± 0.270 n.s. n.s.
OJ 1.71 ± 1.060 0.93 ± 0.38 1.45 ± 1.27 1.38 ± 0.39 n.s
Excretion sodium fraction
SO 0.53 ± 0.100 0.24 ± 0.200 0.56 ± 0.200 0.75 ± 0.100 < 0.01 n.s.
OJ 0.53 ± 0.200 0.34 ± 0.100 0.46 ± 0.200 0.36 ± 0.100 n.s
Urine sodium (mmol/l)
SO 147 ± 18 62 ± 33 140 ± 62 171 ± 41 < 0.002 < 0.01
OJ 145 ± 17 53 ± 21 84 ± 30 99 ± 55 < 0.001
Renin (µU/ml)
SO 1.11 ± 1.610 3.62 ± 3.620 1.14 ± 1.540 0.43 ± 0.950 n.s. n.s.
OJ 1.11 ± 1.520 1.65 ± 3.170 1.40 ± 2.980 2.32 ± 3.270 n.s.
Aldosterone (pg/ml)
SO 561 ± 489 593 ± 266 378 ± 242 302 ± 80 n.s. < 0.03
OJ 561 ± 461 931 ± 381 521 ± 315 624 ± 381 n.s.
ANP (pg/100 µl)
SO 1.88 ± 0.850 2.27 ± 0.630 1.57 ± 0.440 1.76 ± 0.740 n.s. n.s.
OJ 1.84 ± 0.840 1.42 ± 0.530 1.84 ± 0.950 1.95 ± 0.910 n.s.
Endothelin (fmol/ml)
SO 0.34 ± 0.010 0.43 ± 0.110 0.36 ± 0.010 0.35 ± 0.010 n.s. < 0.001
OJ 0.34 ± 0.010 0.82 ± 0.230 0.51 ± 0.120 0.60 ± 0.270 < 0.001
Urine PGE2 (ng/l)
SO 7.56 ± 2.450 15.5 ± 4.40 19.69 ± 13.540 18.17 ± 8.450 < 0.055 < 0.001
OJ 7.56 ± 2.310 26 ± 15.60 47 ± 8.7 41 ± 14.0 < 0.001
Urine PGE2 excreted 53 ± 12 85 ± 23 134 ± 11 123 ± 60 n.s. < 0.001
amount (pg/min) 53 ± 13 226 ± 131 356 ± 91 362 ± 168 < 0.001
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period of OJ. However, studies with similar experimental
models showed a significant reduction in creatinine
clearance at four days of biliary ligation (11,12), and a
rise in serum creatinine in animals submitted to one week
of OJ (7,13). Our study corroborated previous studies
(14,25) that showed that OJ causes a decrease in sodium
excretion and lower sodium concentrations in urine,
which suggests increased sodium reabsorption in
cholestatic rats. In addition, our study could not show a
clear relationship between sodium excretion or sodium
concentration in urine and ANP concentration in urine. In
a prospective study of patients with OJ, our group
showed that obstruction of the biliary tree is linked to a
rise in ANP concentration in plasma (15). The rise in
ANP concentration in the blood from OJ animals did not
reach statistical differences when compared to the SO
group. Nevertheless, it could be feasible that the tenden-
cy of ANP to rise could be statistically significant at the
longest time period of OJ. Another factor to bear in mind
is that our experiment was conducted on rats, and studies
with a rise on ANP have been published in humans (15)
and in rabbits (14). Nonetheless, the concentration of
renin and aldosterone in the serum increased in rats with
biliary obstruction, though only aldosterone levels were
statistically significant. The effects of aldosterone are
sodium retention and potassium excretion in the distal
tubule. Our study found a drop in sodium excretion, and
the concentration of sodium in urine that was related to
the increase in aldosterone concentration, which suggests
a rise in sodium retention in the distal tubule. In this re-
spect, results corroborate clinical studies run by our
group, which showed that patients with OJ suffered a de-
pletion of extracellular volume that is directly related to
biliary obstruction (16), and had renin and aldosterone
levels in the upper range of normality (5).
ET-1 is a peptide with a powerful vasoconstrictor ac-
tion that is involved in the genesis of several diseases,
mainly in the hepato-biliary area. Therefore, it has been
suggested that ET-1 has a key function in serious compli-
cations of hepatic cirrhosis such as portal hypertension
(17) and hepatopulmonary syndrome (18). It was recently
shown that the blocking of ET-1 receptors improved mi-
crocirculation and sinusoidal perfusion in an experimen-
tal model of acute liver failure (19). Our findings indicat-
ed that in experimental OJ there was a rise in plasma
ET-1 concentrations, which reached its peak 24 hours af-
ter the induction of biliary obstruction. However, other
authors have demonstrated that the highest values of
ET-1 occur four to five weeks after biliary ligation asso-
ciated with biliary cirrhosis (20,21). Although in our
study renal function parameters showed no differences
between the OJ and SO groups, the concentration of ET-1
was higher in rats with creatinine clearance below the
mean value, which suggests that rats with higher ET-1 are
at greater risk of renal failure. Nevertheless, other experi-
mental models of OJ have reported renal failure (12,13).
In addition, these studies found increased ET-1 synthesis
in the renal papilla, which may contribute to renal dys-
function and predispose to acute renal failure during OJ
(12). A clinical study of pediatric patients with cirrhosis
showed a negative correlation between plasma ET-1 and
creatinine clearance (22), which corroborates the link be-
tween renal dysfunction and OJ. In addition, it has been
shown that ET-1 induces renal synthesis of PGE2, which
exerts a vasodilatory effect on renal vascular tone (23).
Our study showed increased PGE2 urine secretion in OJ
rats. Moreover, rats with creatinine clearance below the
mean value had less PGE2 content excreted to urine. This
suggests that PGE2 could exert a protective role in kid-
neys against renal function deterioration. Along the same
Vol. 101. N.° 6, 2009 ALTERATION OF THE RENAL REGULATORY HORMONAL PATTERN 411
DURING EXPERIMENTAL OBSTRUCTIVE JAUNDICE
REV ESP ENFERM DIG 2009; 101 (6): 408-412
Fig. 1. Serum endothelin in jaundiced rats with creatinine clearance
over (A) and under (B) mean values. a: p < 0.02.
Fig. 2. Urine PGE2 excreted in jaundiced rats with creatinine clearance
over (A) and under (B) mean values. a: p < 0.03.
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lines, other authors have shown a rise in PGE2 in the
urine of rats with OJ (24). In addition, clinical studies
signaled a normalization of PGE2 in urine after biliary
drainage in patients with OJ (25).
In summary, our study shows that during the first week
after bile duct ligation an increase in plasma ET-1 con-
centrations and a rise in PGE2 secretion to urine were
seen. The stable renal function found in this period might
be related to a compensatory mechanism between hor-
mones regulating sodium and water, as well as vasoactive
hormones.
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